Can we define CD3
+
CD56
+
cells as NKT cells with impunity?
Clin Immunol
.
2021 May:226:108708.
doi: 10.1016/j.clim.2021.108708.
Epub 2021 Mar 1.
Authors
Marzena Lenart
1
,
Krzysztof Pyrć
1
,
Maciej Siedlar
2
Affiliations
1
Malopolska Centre of Biotechnology, Jagiellonian University, Krakow, Poland.
2
Department of Clinical Immunology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland. Electronic address: misiedla@cyf-kr.edu.pl.
PMID:
33662591
PMCID:
PMC7919538
DOI:
10.1016/j.clim.2021.108708
No abstract available
Keywords:
CD3(+)CD56(+) cells; COVID-19; NKT cells.
Publication types
Letter
Comment
MeSH terms
CD3 Complex
CD56 Antigen
COVID-19*
Humans
Natural Killer T-Cells*
SARS-CoV-2
Substances
CD3 Complex
CD56 Antigen